PLUS THERAPEUTICS, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
PSTV Company Description
Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focuses on the discovery, development, and delivery of complex treatments for patients battling cancer and rare diseases. Its product pipeline includes Patented RNL and Patented DocePLUS.
PSTV Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view PSTV Smart Score
Score Breakdown
PSTV Company Description
Show More
Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focuses on the discovery, development, and delivery of complex treatments for patients battling cancer and rare diseases. Its product pipeline includes Patented RNL and Patented DocePLUS. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of PSTV by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PSTV's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on PSTV's company Twitter account
WallStreetBets
Number of mentions of PSTV in WallStreetBets Daily Discussion
PSTV News
Recent insights relating to PSTV
CNBC Recommendations
Recent picks made for PSTV stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in PSTV
Corporate Flights
Flights by private jets registered to PSTV
Our Analysis